Article: Purdue Pharma L.P. Announces End of OxyContin(R) Patent Lawsuit With IMPAX Laboratories.

STAMFORD, Conn., May 25 /PRNewswire/ -- Purdue Pharma L.P. announced today that the United States District Court for the Southern District of New York has granted a request by both companies to dismiss a lawsuit brought by Purdue against IMPAX concerning certain Purdue Pharma patents on OxyContin(R) (oxycodone HCl controlled-release) Tablets.

Under the terms of the settlement agreement announced on March 30th, 2007, IMPAX Laboratories has acknowledged that Purdue Pharma's OxyContin patents are valid, enforceable and infringed by IMPAX's extended-release oxycodone products and Purdue agreed it will not pursue damages against IMPAX for past infringement. Purdue ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!